marketcap
Facebook
Twitter
Telegram
Report an ErrorKindred Biosciences, Inc. Financial Ratios 2011-2024 | KIN
Annual Financial Ratios Kindred Biosciences, Inc.
| 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|
P/E |
-9.0 | -5.7 | -6.1 | -7.2 | -5.7 | -2.4 | -4.4 | -14.6 | - | - |
P/S |
4.7 | 82.6 | 155.3 | - | - | - | - | - | - | - |
EV/EBITDA |
-18.5 | -5.9 | -4.9 | -6.0 | -5.5 | -1.7 | -3.9 | 0.9 | - | - |
PEG |
0.14 | 9.16 | -0.2 | -0.81 | 0.33 | 0.49 | -0.16 | -0.08 | - | - |
P/B |
2.9 | 4.3 | 3.3 | 2.6 | 2.2 | 0.9 | 1.2 | 1.0 | - | - |
P/CF |
-14.6 | -5.4 | -5.2 | -8.0 | -6.5 | -2.8 | -5.3 | -38.8 | - | - |
ROE % |
-32.30 | -74.94 | -54.48 | -36.47 | -39.01 | -35.52 | -27.41 | -6.66 | - | - |
ROA % |
-22.75 | -53.84 | -46.67 | -34.00 | -36.54 | -34.07 | -26.63 | -6.43 | - | - |
ROCE % |
-17.68 | -60.28 | -56.14 | -37.33 | -38.42 | -35.68 | -27.49 | -6.67 | - | - |
DSO |
5.4 | 79.2 | 167.6 | - | - | - | - | - | - | - |
DIO |
16.3 | 2622.8 | 4021.8 | - | - | - | - | - | - | - |
DPO |
11.4 | 781.0 | 4028.5 | - | - | - | - | - | - | - |
All numbers in USD currency